GrowPros recent equity interest and vision as a diversified cannabis venture firm

Brown-Ryan-GrowProsMarch 9, 2015 — In a special InvestorIntel interview, Publisher Tracy Weslosky speaks with Ryan Brown, CEO of GrowPros Cannabis Ventures Inc. (CSE: GCI) about the recent agreement with MMPR applicant Herbaceous Inc. who has been issued a ready to build letter as well as GrowPros’ ongoing mandates focused on equipment and the service aspect of the industry. As a leading expert in the sector, Ryan also provides an update on the development of the Canadian MMPR licensing system and renewed market interest.

Tracy Weslosky: Ryan I really like that we’re having the opportunity to speak with you because you’re a really well-respected hydroponic expert in the overall cannabis and medicinal marijuana sector. As a leading expert in this sector, can you tell us a little bit about your mandate?

Ryan Brown: Yes, Growpros’ mandate is to be a diversified venture firm. We’re looking at investing into many different facets of this rapidly changing and emerging industry.

Tracy Weslosky: Of course you just put out some really big news. You just announced that you invested in a company that came to you, right, that’s been issued a ready to build letter?

Ryan Brown: Yeah. One of the areas that we’re focusing on is applicant producers that are in the late stages of the application process. This company contacted us — they were looking for capital for some restructuring of their internal operations. We made a deal with them, which in exchange for 10% equity in their company we would get their business ready for capital investment then in turn we would introduce them to some private capital that is willing to invest in this project.

Tracy Weslosky: Of course, for everyone out there we’re trying to bring investors who might not normally have invested in the medicinal marijuana sector into the Canadian market because we have a very sophisticated infrastructure as we’re attempting to build with the MMPR licensing system. Can you explain a little bit more about this please?

Ryan Brown: Well, what you have right now is 14 licensed companies as well as another 7 that are licensed to produce. The industry is growing. The amount of patients registered with the system is increasing tenfold every month. We see this as being a long-term opportunity for production, distribution as well as all of the industries that cater to these production facilities for the next year to two years.

Tracy Weslosky: Of course, you have some top investors on your board of directors. With an interesting model, GrowPros is seeking acquisitions with revenue?

Ryan Brown: Yeah, we’re really focused on late stage applicants as well as companies that are generating revenue within the medical cannabis industry or those generating revenue looking at reaching out into the medical cannabis industry.

Tracy Weslosky: Of course, we see a market turnaround happening right now. Companies that are leaders, like yourself, that are — have revenue are obviously going to be on the forefront of a lot of investors’ stock watch. Can you tell us any of the deals that you currently have in place?

Ryan Brown: Yeah, well, we’re looking at, obviously looking at the equipment sector, the lights, the LD equipment that goes into these large production facilities as well as the patient acquisition and a few interesting technology opportunities that have presented themselves in and around the patient end of the industry and certain technologies that can help the licensed producers as well as these care clinics manage their patient flow and run more efficient businesses….for more information, click here

Disclaimer: GrowPros Cannabis Ventures Inc. (CSE: GCI) is an advertorial member of InvestorIntel.




GrowPros Cannabis offers a bridge between medicinal marihuana companies and institutional financing

GrowProsJanuary 6, 2015 — In a special InvestorIntel interview, Publisher Tracy Weslosky speaks with Ryan Brown, CEO  of GrowPros Cannabis Ventures Inc. (CSE: GCI) about the recent merger between Mazorro and GrowPros and their acquisition mandate for 2015

Tracy Weslosky: You just recently made an announcement about a merger that you made, yes? Mazzoro is now GrowPros Cannabis Ventures — can you tell us a little bit about this?

Ryan Brown: We were looking for a public vehicle to enter into the marijuana space and they were looking for an entity to bring into their company as they diversified into the cannabis industry so it was a perfect match. We’re a good fit. Everything has been working out great so far.

Tracy Weslosky: When I was looking at your overall business model Ryan, I think there were 27 million shares outstanding and with this merger you now have 50 million shares. Is this correct?

Ryan Brown: Yes, that’s correct.

Tracy Weslosky: It’s also my understanding that your company is going to be seeking new acquisitions. Is this correct?

Ryan Brown: Absolutely. We see ourselves as a bridge between companies that are currently operating within the cannabis industry and institutional financing as well as companies that are looking to get into the medical marijuana industry that really don’t have a frame of reference. They don’t have the background to properly position themselves in this new and emerging industry and with our background and the team that we’ve assembled at GrowPros Cannabis Ventures we’ve had some very good feedback from companies that we’re working with, working on developing some joint ventures with to help them get into the newly budding cannabis industry.

Tracy Weslosky: Of course, everybody’s got the race for a medicinal marijuana license. Where are you in the process?

Ryan Brown: We are currently working on two applications; one that is in the preliminary process, but it’s actually moved quite quickly considering it was a later application. We’re working with another one that has a ready to build facility that we’re able to start construction hopefully first quarter of 2015.

Tracy Weslosky: For all of you out there in InvestorIntel audience you’re wondering what’s really happening with the medicinal marijuana. I’d like you to give us a little bit of an overview about the sector and why we should invest in your company.

Ryan Brown: Well, obviously the first initial rush was the rush to get the coveted MMPR production license through Health Canada. I think as the market has observed the economics of running these large highly regulated production facilities is a little more difficult at this infancy stage of the industry so we took the stance of wanting to create a diversified public vehicle that will be investing in all areas of the medical marijuana business. In a brand new industry no one knows which way this industry is going to go and we feel that having flexibility and being well diversified in the industry will yield the best returns for our investors…to see the rest of the GrowPros Cannabis Ventures interview, click here

Disclaimer: GrowPros Cannabis Ventures is an advertorial member of InvestorIntel.